Locum Malignant Hematologist in Myeloma and Lymphoma

Locum Malignant Hematologist in Myeloma and Lymphoma

Princess Margaret Cancer Centre, University Health Network and

Sinai Health System

Division of Medical Oncology and Hematology

The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) and Sinai Health Systems (SHS) are seeking to recruit a Locum Malignant Hematologist to work within the Malignant Hematology Program.  This position is for a period of 9-12 months to cover a maternity leave at Princess Margaret Cancer Centre in Toronto. This would entail covering 3-4 half day clinics per weeks of myeloma and lymphoma patients, from newly diagnosed, to those undergoing autologous stem cell transplantation or CART therapy, as well as those enrolled on clinical trials. Depending on interest and need, there may be 2-4 weeks of inpatient attending responsibilities, covering complex lymphoma, myeloma and ASCT patients, +/- cell therapy patients, and MRP weekend call every 2-3 months. We are a group of 12 lymphoma and myeloma physicians and the locum physician will be fully supported clinically by the group. Some experience with malignant hematology and transplant/cell therapy would be an asset, but not required. There is an immediate opening available. The successful applicant will have a demonstrated expertise in oncology and hematology and have a strong passion for the medical care of cancer patients. The successful applicant will have a proven ability to work independently, as well as interacting with a multidisciplinary team in the management of patients with hematologic malignancies.

Ranked in the top 10 on Newsweek’s list of the World’s Best Specialized Hospitals for Oncology in 2023, the Princess Margaret Cancer Centre continues to be on the frontiers of medical, surgical and radiation oncology, embracing the latest technology and international best-practices and setting standards for patient care. The Princess Margaret Cancer Centre includes the Ontario Cancer Institute (OCI), while Sinai Health System includes the Lunenfeld-Tanenbaum Research Institute. These are world-class basic and translational research institutes with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics. The close association between clinicians and scientists within both institutions provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing for exceptional bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre and Sinai Health System support active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Both institutions are affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Princess Margaret Cancer Centre and Sinai Health System are teaching hospitals, dedicated to educating the world’s future top cancer experts. Our role as internationally respected teaching hospitals keeps us and our students abreast of the latest medical developments and the most advanced technology.

The successful applicant must hold an MD degree, have, or be eligible for specialist designation certification by the Royal College of Physician and Surgeons of Canada in Malignant Hematology (or equivalent), and have, or be eligible for independent practice licensure with the College of Physicians and Surgeons of Ontario. The successful applicant must also hold a valid OHIP billing number, and obtain and maintain privileges at University Health Network and Sinai Health System. Salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. A highly attractive remuneration package is available.

Should you be interested in this exciting opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three (3) referees to:

Dr. Amit Oza - Chief, Division of Medical Oncology and Hematology

C/o Christina Gulesserian –Administrative Coordinator

Princess Margaret Cancer Centre, University Health Network

Suite 700U: 7-925, 610 University Avenue, Toronto, Ontario, Canada, M5G 2M9 Office: 416-946-4501 ext 5503

Fax: 416.946.2082 E-mail: [email protected]

Applications will be accepted until all positions are filled.

For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit: www.theprincessmargaret.ca

For more information on Sinai Health and our world-renowned programs, visit:


For more information about the Department of Medicine at the University of Toronto, please visit our website at https://www.deptmedicine.utoronto.ca

All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.

Diversity Statement

The University of Toronto, University Health Network and Sinai Health System are strongly committed to diversity within its community and especially welcomes applications from racialized persons/persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ2S+ persons, and others who may contribute to the further diversification of ideas.

Accessibility Statement

The University strives to be an equitable and inclusive community, and proactively seeks to increase diversity among its community members. Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission. The University is committed to the principles of the Accessibility for Ontarians with Disabilities Act (AODA). As such, we strive to make our recruitment, assessment and selection processes as accessible as possible and prove accommodations as required for applicants with disabilities